WEBINAR – A Novel Approach: Brazil-US Partnerships in Health Science and Human Medicine

Brazil and the United States share long-established innovative partnerships in health, science, and biomedicine.  Through direct investment and public-private partnerships, scientists have come together to fight viruses such as HIV / AIDS, Zika, and COVID-19.  Now, for the first time in history, Brazil is initiating research in specific fields of healthcare and science – and has partnered with laboratories in the United States to finance brain cancer research through The Medulloblastoma Initiative (MBI), founded in 2021 by Brazilian Fernando Goldsztein.  MBI has established an unprecedented partnership between laboratories and institutions in Brazil and the United States to operationalize funding for world-class medulloblastoma research, with every dollar raised directly invested in finding a cure.

Considering this novel approach, the Brazilian-American Chamber of Commerce has united a group of medical experts, scientists, and business leaders to speak on Brazil-US exchanges and joint advancements made in health science and human medicine.  The program featured MBI Founder Fernando Goldsztein, who shared how MBI was created and his mission to fund pediatric cancer research.  Mr. Goldsztein was joined by Dr. Roger Packer, the  Gilbert Distinguished Professor of Neurofibromatosis, who serves as Director of both the Gilbert Neurofibromatosis Institute and the Brain Tumor Institute of Children’s National Hospital.  Dr. Packer is the lead investigator from a consortium of 13 laboratories funded by MBI and will share how this group is advancing in preparations to submit clinical trials to the US Food and Drug Administration in 2024.  One of Brazil’s most successful entrepreneurs and Director of Instituto Ling, William Ling shared insights as one of MBI’s first supporters.  Career diplomat and Head of the Consulate General of Brazil in Asunción, Paraguay, Otávio Brandelli shared his experience building international awareness for MBI, combining science with an unparalleled business model that focuses on results that will change the future of humanity.

Watch the highlight video on this global journey to hear from pioneers leading and supporting Brazil-US health science partnerships and the extraordinary advancements they have achieved.

WELCOMING REMARKS:

Simoni Morato, President & Chairperson of the Board, Brazilian-American Chamber of Commerce;  President & CEO, Safra National Bank of New York

INTRODUCTORY REMARKS & SPEAKER:

Fernando Goldsztein, Founder,  The Medulloblastoma Initiative (MBI)

MODERATOR:

Kieran McManus, Partner, PricewaterhouseCoopers

SPEAKERS:

Ambassador Otávio Brandelli, Head of the Consulate General of Brazil in Asunción, Paraguay; Former Permanent Representative of Brazil to the Organization of American States (OAS)

William Ling, Chairperson of the Board, Évora; Director, Instituto Ling

Roger J. Packer,MD, Gilbert Distinguished Professor of Neurofibromatosis; Director, Gilbert Neurofibromatosis Institute; Director, Brain Tumor Institute of Children’s National Hospital; Professor of Neurology and Pediatrics, George Washington University; Clinical Professor of Neurosurgery, University of Virginia

Please click here to access the speaker bios

REGISTRATION INFORMATION:

Members: Free
Non-Members: $15